Drugs for Tethered Spinal Cord Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 43)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Drospirenone |
Approved |
Phase 3 |
|
67392-87-4 |
68873 |
Synonyms:
(6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-1,3',4',6,6a,7,8,9,10,11,12,13,14,15,15a,16-Hexadecahydro-10,13-dimethylspiro-(17H-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'H)-furan)-3,5'(2H)-dione
1, 2-Dihydrospirorenone
1,2-dihydro-spirorenone
1,2-dihydro-Spirorenone
1,2-Dihydrospirorenone
15,16]-17alpha-pregn-4-ene-21,17-carbolactone
15b,16b-dimethylene-3-oxo-17a-pregn-4-ene-21,17-carbolactone
15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
15beta,16beta-Dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
15-beta,16-beta-Dimethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactone
15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21,17-carbolactone
15β,16β-Dimethylene-3-oxo-17α-pregn-4-ene-21,17-carbolactone
17-Hydroxy-6beta,7beta:15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid, gamma-lactone
3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-7'H,16'H-dicyclopropa[6,7
67392-87-4
6b,7Beta
6beta,7beta
6-beta,7-beta
6beta,7Beta
6beta,7beta,15beta,16beta-dimethylen-3-oxo-17alpha-pregn-4-en-21,17-carbolacton
6beta,7beta,15beta,16beta-Dimethylen-3-oxo-17alpha-pregn-4-en-21,17-carbolacton
6beta,7beta,15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17 carbolactone
6β,7beta
6β,7β
6β,7β,15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21,17 carbolactone
AC1L2AMM
Angeliq, Drospirenone
BRN 4765500
C035144
|
C24H30O3
CCRIS 6523
CHEBI:50838
CHEMBL1509
CID68873
D03917
DB01395
Dehydrospirorenone
Dihydrospirorenone
Drospirenona
Drospirenona [INN-Spanish]
Drospirenone
Drospirénone
Drospirenone (JAN/USAN/INN)
Drospirenone [INN]
Drospirenonum
Drospirenonum [INN-Latin]
DRSP
EINECS 266-679-2
LS-146115
S1377_Selleck
SH-470
Spiro(17H-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'H)-furan)-3,5'(2H)-dione, 1,3',4',6,7,8,9,10,11,12,13,14,15,16,20,21-hexadecahydro-10,13-dimethyl-, (6R-(6alpha,7alpha,8beta,9alpha,10beta,13beta,14alpha,15alpha,16alpha,17beta
UNII-N295J34A25
ZINC03927200
ZK 30595
ZK30595
ZK-30595
|
|
2 |
|
Mineralocorticoids |
|
Phase 3 |
|
|
|
3 |
|
Drospirenone and ethinyl estradiol combination |
|
Phase 3 |
|
|
|
4 |
|
Mineralocorticoid Receptor Antagonists |
|
Phase 3 |
|
|
|
5 |
|
diuretics |
|
Phase 3 |
|
|
|
6 |
|
Diuretics, Potassium Sparing |
|
Phase 3 |
|
|
|
7 |
|
Calcium, Dietary |
|
Phase 3 |
|
|
|
8 |
|
Calcium |
Nutraceutical |
Phase 3 |
|
7440-70-2 |
271 |
Synonyms:
Blood coagulation factor XIII
Ca
Ca(2+)
Ca2+
Calcio
Calcium
Calcium element
CALCIUM ion
Calcium, doubly charged positive ion
Calcium, elemental
Coagulation factor XIII
Elemental calcium
Factor XIII
|
Factor XIII a chain
Factor XIII a-chain
Factor XIII transamidase
Factor XIII, coagulation
Fibrin stabilizing factor
Fibrinase
Kalzium
Laki lorand factor
Laki-lorand factor
Stabilizing factor, fibrin
Transamidase, factor XIII
XIII, coagulation factor
|
|
9 |
|
Clotrimazole |
Approved, Vet_approved |
Phase 2 |
|
23593-75-1 |
2812 |
Synonyms:
(Chlorotrityl)imidazole
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole
1-(a-(2-Chlorophenyl)benzhydryl)imidazole
1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole
1-(O-chloro-a,a-Diphenylbenzyl)imidazole
1-(O-chloro-alpha,alpha-Diphenylbenzyl)imidazole
1-(o-Chlorotrityl)imidazole
1-(O-Chlorotrityl)imidazole
1-(o-Chloro-α,α-diphenylbenzyl)imidazole
1-(O-chloro-α,α-diphenylbenzyl)imidazole
1-(α-(2-chlorophenyl)benzhydryl)imidazole
1-(α-(2-Chlorophenyl)benzhydryl)imidazole
117829-71-7
23593-75-1
33894_FLUKA
33894_RIEDEL
3ACDFDF8-38E3-4368-85D0-BDF8AE1E6591
AB00051951
AC1L1EIW
AC-279
B 5097
BAY 5097
Bay b 5097
BAY b 5097
Bay b 9057
BAY b5097
BAY-5097
Bay-B 5097
BAYb 5097
Bayer brand 1 OF clotrimazole
Bayer Brand 1 of Clotrimazole
Bayer brand 2 OF clotrimazole
Bayer Brand 2 of Clotrimazole
BIDD:GT0450
BIDD:PXR0036
Bio-0442
BPBio1_000126
BRN 0622318
BSPBio_000114
BSPBio_002057
C 6019
C06922
C22H17ClN2
C6019_SIGMA
Canesten
Canesten 1-day cream combi-pak
Canesten 1-Day Cream Combi-Pak
Canesten 1-day therapy
Canesten 1-Day Therapy
Canesten 3-day therapy
Canesten 3-Day Therapy
Canesten 6-day therapy
Canesten 6-Day Therapy
Canesten combi-pak 1-day therapy
Canesten Combi-Pak 1-Day Therapy
Canesten combi-pak 3-day therapy
Canesten Combi-Pak 3-Day Therapy
Canesten cream
Canesten Cream
Canesten solution
Canesten Solution
Canestene
Canestine
Canifug
CAS-23593-75-1
CCRIS 6245
CHEBI:3764
CHEMBL104
Chlotrimazole
CID2812
Cimitidine
Clomatin
Clotrimaderm
Clotrimaderm cream
Clotrimazol
Clotrimazol [INN-Spanish]
clotrimazole
Clotrimazole
Clotrimazole (JP15/USP/INN)
Clotrimazole [USAN:INN:BAN:JAN]
Clotrimazole schering brand
Clotrimazole Schering Brand
Clotrimazolum
Clotrimazolum [INN-Latin]
clotrimeizol
CPD000058306
CPD-8926
Cutistad
D00282
D003022
DB00257
Desamix F
DivK1c_000665
DRG-0072
EINECS 245-764-8
Empecid
Esparol
EU-0100315
FB 5097
FB b 5097
Fem care
Fem Care
FemCare
Gino-Lotremine
Gyne lotrimin
Gyne-lotrimin
Gyne-Lotrimin
Gyne-lotrimin 3
Gyne-Lotrimin 3
Gyne-lotrimin 3 combination pack
Gyne-Lotrimin 3 Combination Pack
Gyne-lotrimin combination pack
Gyne-Lotrimin Combination Pack
Gyne-lotrimin3
Gyne-lotrimin3 combination pack
Gynix
HMS1568F16
HMS1920O21
HMS2051E11
HMS2091G10
HMS502B07
HSDB 3266
I01-3474
IDI1_000665
|
Kanesten
KBio1_000665
KBio2_001823
KBio2_004391
KBio2_006959
KBio3_001277
KBioGR_000850
KBioSS_001823
Klotrimazole
Lopac0_000315
Lopac-C-6019
Lotrimax
Lotrimin
Lotrimin (TN)
Lotrimin af
Lotrimin Af
Lotrimin af cream
Lotrimin AF Cream
Lotrimin af jock-itch cream
Lotrimin AF Jock-Itch Cream
Lotrimin af lotion
Lotrimin AF Lotion
Lotrimin af solution
Lotrimin AF Solution
Lotrimin cream
Lotrimin Cream
Lotrimin lotion
Lotrimin Lotion
Lotrimin solution
Lotrimin Solution
Lotrisone
LS-78271
MLS000028502
MLS000758243
MLS001423972
MolPort-002-557-756
mono-Baycuten
Monobaycuten
Mono-baycuten
Mycelax
Mycelex
Mycelex (TN)
Mycelex 7
Mycelex cream
Mycelex Cream
Mycelex g
Mycelex G
Mycelex otc
Mycelex OTC
Mycelex solution
Mycelex Solution
Mycelex troches
Mycelex Troches
Mycelex twin pack
Mycelex Twin Pack
Mycelex: mycosporinrimazole
Mycelex: MycosporinRimazole
Mycelex-7
Mycelex-7 combination pack
Mycelex-7 Combination Pack
Mycelex-g
Mycelex-G
myclo Cream
Myclo Cream
myclo Solution
Myclo Solution
myclo Spray solution
Myclo Spray Solution
myclo-Gyne
Myclo-Gyne
Mycofug
Mycosporin
Mykosporin
Nalbix
NCGC00015251-01
NCGC00015251-02
NCGC00015251-03
NCGC00015251-09
NCGC00093761-01
NCGC00093761-02
NCGC00093761-03
NCGC00093761-04
NCGC00093761-05
NCGC00093761-06
nchembio.65-comp9
nchembio790-comp30
NCIMech_000609
neo-Zol cream
Neo-Zol Cream
NINDS_000665
NSC 257473
NSC257473
Otomax
Pan-Fungex
Pedisafe
Prestwick_120
Prestwick0_000267
Prestwick1_000267
Prestwick2_000267
Prestwick3_000267
QTL1_000024
Rimazole
S1606_Selleck
SAM001247056
Schering brand OF clotrimazole
Schering Brand of Clotrimazole
SMR000058306
SPBio_000176
SPBio_002333
Spectrum_001343
SPECTRUM1500200
Spectrum2_000128
Spectrum3_000359
Spectrum4_000295
Spectrum5_000781
Stiemazol
STK700023
Tibatin
Trimysten
Trivagizole 3
UNII-G07GZ97H65
Veltrim
ZINC03807804
|
|
10 |
|
Mycophenolic acid |
Approved |
Phase 2 |
|
24280-93-1 |
446541 |
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acid, mycophenolic
Acide mycophenolique
acido Micofenolico
Acido micofenolico
Acidum mycophenolicum
Melbex
|
micofenolico acido
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolic acid
Mycophenolsaeure
Mycophenolsäure
Myfortic
|
|
11 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 2 |
|
22916-47-8 |
4189 |
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
Aflorix(nitrate)
AKOS001574474
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
Brentan
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
Conofite(nitrate)
CPD-4501
D00416
Dactarin
Daktarin IV
DB01110
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Esteve brand OF miconazole
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
Janssen cilag brand OF miconazole
Janssen-cilag brand OF miconazole
Johnston and johnston brand OF miconazole nitrate
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
Lotrimin AF(nitrate)
LS-78378
MCZ
Micantin (nitrate)
Miconasil nitrate
Miconasil Nitrate
Miconazol
|
Miconazol [INN-Spanish]
miconazole
Miconazole
Miconazole (JP15/USP/INN)
Miconazole [USAN:BAN:INN:JAN]
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole esteve brand
Miconazole janssen-cilag brand
Miconazole nitrate
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MJR 1762
MLS002222203
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
Nitrate, miconasil
Nitrate, miconazole
Novo-Miconazole Vaginal Ovules
NSC 170986
NSC169434
NSC170986
Oprea1_091955
Prestwick_335
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
Spectrum_000965
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
STK834405
STOCK1S-93556
UNII-7NNO0D7S5M
Vusion
Zimycan
|
|
12 |
|
Dermatologic Agents |
|
Phase 2 |
|
|
|
13 |
|
Immunologic Factors |
|
Phase 2 |
|
|
|
14 |
|
Antitubercular Agents |
|
Phase 2 |
|
|
|
15 |
|
Immunosuppressive Agents |
|
Phase 2 |
|
|
|
16 |
|
Antifungal Agents |
|
Phase 2 |
|
|
|
17 |
|
Cyclosporins |
|
Phase 2 |
|
|
|
18 |
|
Thymoglobulin |
|
Phase 2 |
|
|
|
19 |
|
Antibiotics, Antitubercular |
|
Phase 2 |
|
|
|
20 |
|
Antirheumatic Agents |
|
Phase 2 |
|
|
|
21 |
|
Calcineurin Inhibitors |
|
Phase 2 |
|
|
|
22 |
|
Antilymphocyte Serum |
|
Phase 2 |
|
|
|
23 |
|
Cefoxitin |
Approved |
|
|
35607-66-0 |
441199 |
Synonyms:
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-{[(aminocarbonyl)oxy]methyl}-7-(methyloxy)-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-4-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(thiophen-2-enyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
3-[(carbamoyloxy)methyl]-7alpha-methoxy-7beta-[(2-thienylacetyl)amino]-3,4-didehydrocepham-4-carboxylate
3-[(carbamoyloxy)methyl]-7alpha-methoxy-7beta-[(thiophen-2-yl)acetamido]-3,4-didehydrocepham-4-carboxylic acid
33564-30-6
35607-66-0
AB00513931
AC-1303
AC1L9AQF
AC1L9SPP
BIDD:GT0505
BPBio1_000863
BSPBio_000783
BSPBio_003101
C06887
C08106
cefoxitin
Cefoxitin
Cefoxitin (USAN/INN)
Cefoxitin sodium
CEFOXITIN SODIUM
Cefoxitin sodium (JAN/USP)
Cefoxitin sodium salt
Cefoxitina
Cefoxitine
Cefoxitinum
Ceftoxitin
Cephoxitin
CFX
CHEBI:209807
CHEBI:53655
CHEMBL1200530
CHEMBL996
CID441199
CID441392
CPD000058809
CPD-9233
D00913
D02345
DB01331
DivK1c_000576
|
HMS1570H05
HMS1921F14
HMS2092P11
HMS501M18
IDI1_000576
KBio1_000576
KBio2_001879
KBio2_004447
KBio2_007015
KBio3_002601
KBioGR_000626
KBioSS_001879
Mefoxin
Méfoxin
Mefoxin (TN)
Mefoxitin
Merck brand OF cefoxitin sodium
Merck frosst brand OF cefoxitin sodium
Merck sharp and dohme brand OF cefoxitin sodium
MLS000028557
MLS001076334
MLS002222151
MolPort-003-666-398
MSD Brand OF cefoxitin sodium
NCGC00093351-02
NCGC00093351-03
NINDS_000576
Prestwick_12
Prestwick0_000832
Prestwick1_000832
Prestwick2_000832
Prestwick3_000832
Rephoxitin
SAM002564251
SMR000058809
Sodium, cefoxitin
SPBio_000771
SPBio_002704
Spectrum 001399
Spectrum_001399
SPECTRUM1502031
Spectrum2_000676
Spectrum3_001491
Spectrum4_000153
Spectrum5_001145
ZINC03830449
|
|
24 |
|
Cefotaxime |
Approved |
|
|
63527-52-6 |
5742673 456256 |
Synonyms:
(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-3-(acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R,Z)-3-(acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
60846-21-1
63527-52-6
63527-53-7
64485-93-4 (mono-hydrochloride salt)
AC1L1E42
AC1L9UKL
AC1NSF5T
AC1NSF6T
AC1NUIF8
AC1NX3QV
AC1NZU9Q
AC1O712I
AC1O7G8N
AC1OC9NB
AC-217
AKOS003286450
Aventis brand OF cefotaxime sodium
Aventis pharma brand OF cefotaxime sodium
Benaxima
BIDD:GT0681
Biosint
BPBio1_000240
BRD-K78364995-236-03-5
BRD-K99586414-236-02-3
BSPBio_000218
BSPBio_001961
C06885
C16H17N5O7S2
CE3
Cefotaxim
Cefotaxim Hikma
Cefotaxim Hikma (TN)
Cefotaxima
Cefotaxima [INN-Spanish]
cefotaxime
Cefotaxime
Céfotaxime
Cefotaxime (INN)
Cefotaxime [INN:BAN]
Cefotaxime acid
Cefotaxime sodium
Cefotaximum
Cefotaximum [INN-Latin]
Cefradil
Cephotaxim
Cephotaxime
CHEBI:204928
CHEMBL102
CID2632
CID456256
CID5361298
CID5361354
|
CID5479527
CID5742673
CID5916965
CID6540461
CID6604086
CID6914272
CID7566336
CID9868614
Claforan
Claforan (*Sodium salt*)
D07647
DB00493
DivK1c_000767
EINECS 264-299-1
Fotexina
Fustery brand OF cefotaxime sodium
Galen brand OF cefotaxime sodium
HMS2090M11
Hoechst brand OF cefotaxime sodium
IDI1_000767
KBio1_000767
KBio2_000548
KBio2_003116
KBio2_005684
KBio3_001181
KBioGR_000736
KBioSS_000548
Kendrick
Klaforan
Liomont brand OF cefotaxime sodium
Lopac0_000278
LS-149920
LS-187246
Merck brand OF cefotaxime sodium
MolPort-002-339-742
MolPort-005-934-578
MolPort-006-834-754
NCGC00021126-01
NINDS_000767
Pisa brand OF cefotaxime sodium
Prestwick0_000139
Prestwick1_000139
Prestwick2_000139
Prestwick3_000139
Primafen
RU 24662
Ru-24756
Sodium, cefotaxime
SPBio_000138
SPBio_002157
Spectrum_000108
Spectrum2_000119
Spectrum3_000331
Spectrum4_000268
Spectrum5_000667
STK383264
Taporin
UNII-N2GI8B1GK7
Viken brand OF cefotaxime sodium
|
|
25 |
|
Rifampicin |
Approved |
|
|
13292-46-1 |
5381226 5458213 |
Synonyms:
13292-46-1
1-b]furan-21-yl acetate
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
46713_FLUKA
46713_RIEDEL
62534-43-4
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
83907_FLUKA
83907_SIGMA
8CI)
Abrifam
Archidyn
Arficin
Arzide
AZT + Rifampin
Ba 41166
Ba 41166/E
BA-41166E
Benemicin
Benemycin
BIDD:PXR0014
Bio-0621
BPBio1_000561
BSPBio_000509
C06688
C43H58N4O12
CAS-13292-46-1
CCRIS 551
CHEBI:28077
CHEBI:455936
CHEMBL180
CID5381226
CID5388984
CID5458213
CID5702112
CID6604339
CID6708473
CID6842115
CID6912767
CID6913622
CPD001906767
D00211
DB01045
Dione 21-acetate
Dipicin
DivK1c_000550
Doloresum
DRG-0109
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
HMS1569J11
HMS1920P08
HMS2089F12
HMS2092G09
HMS501L12
HSDB 3181
KBio1_000550
KBio2_000919
KBio2_003487
KBio2_006055
KBio3_003018
KBioGR_001780
KBioSS_000919
L-5103
L-5103 Lepetit
LS-7689
MLS000028552
MLS001148237
MLS001333745
MolPort-000-767-051
MolPort-002-513-586
MolPort-003-666-281
MolPort-006-395-891
NCGC00016699-01
NCGC00017365-01
NCGC00018178-01
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00160500-01
nchembio884-comp4
|
NCI60_000309
NINDS_000550
NSC 113926
NSC113926
NSC-113926
Piperine & Rifampicin
Prestwick_833
Prestwick0_000525
Prestwick1_000525
Prestwick2_000525
Prestwick3_000525
R/AMP
R0079
R3501_SIAL
R3501_SIGMA
R5777_SIGMA
R7382_SIGMA
Ramp
RAMP
R-Cin
Reserpine & Rifampicin
Rf
Rfamipicin
RFP
Rifa
Rifadin
Rifadin (TN)
Rifadin I.V
Rifadin I.V.
Rifadin Iv
Rifadin IV
Rifadin, Rimactane, Rifampicin, Rifampin
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
Rifamicin AMP
Rifamor
Rifampicin
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin (JP15/INN)
Rifampicin [INN:BAN:JAN]
Rifampicin SV
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
rifampin
Rifampin
Rifampin (USP)
Rifampin [USAN]
Rifamsolin
Rifamycin
Rifamycin Amp
Rifamycin AMP
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactane (TN)
Rimactazid
Rimactin
Rimactizid
Rimazid
Rimycin
RMP
Rofact
S1764_Selleck
SAM002264646
Sinerdol
SMR000058322
SMR000653525
SPBio_002430
Spectrum_000439
SPECTRUM1500529
Spectrum3_001837
Spectrum4_001250
Spectrum5_002018
STK080143
TNP00313
Tubocin
UNII-VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
|
|
26 |
|
Phenylephrine |
Approved |
|
|
59-42-7 |
6041 |
Synonyms:
(-)-m-Hydroxy-a-(methylaminomethyl)benzyl alcohol
(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol
(−)-m-hydroxy-α-(methylaminomethyl)benzyl alcohol
(-)-m-Hydroxy-α-(methylaminomethyl)benzyl alcohol
(R)-2-Hydroxy-2-(3-hydroxyphenyl)-N-methylethylamine
(R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol
1416-03-1
3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol
59-42-7
61-76-7 (hydrochloride)
AC1L1LO9
AC1Q40UF
Adrianol
Ah-Chew
AI3-02402
Ak-dilate
AK-Dilate
Ak-nefrin
AK-Nefrin
Alcon efrin
Alcon Efrin
Alconefrin nasal drops 12
Alconefrin Nasal Drops 12
Alconefrin nasal drops 25
Alconefrin Nasal Drops 25
Alconefrin nasal drops 50
Alconefrin Nasal Drops 50
Alconefrin nasal spray 25
Alconefrin Nasal Spray 25
Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)- (9CI)
BIDD:GT0157
Biomydrin
BSPBio_002420
C07441
CCRIS 8464
CHEBI:8093
CHEMBL1215
CID6041
Cyclomydril
D08365
DB00388
Dilatair
Dimetane
Dionephrine
DivK1c_000597
Doktors
Duration
EINECS 200-424-8
EINECS 215-810-1
Fenilefrina
Fenilefrina [INN-Spanish]
HSDB 3383
IDI1_000597
I-phrine
I-Phrine
Isophrim
Isophrin
isopto Frin
Isopto Frin
KBio1_000597
KBio2_001581
KBio2_004149
KBio2_006717
KBio3_001640
KBioGR_001313
KBioSS_001581
l-(3-Hydroxyphenyl)-N-methylethanolamine
L-(3-Hydroxyphenyl)-N-methylethanolamine
l-1-(m-Hydroxyphenyl)-2-methylaminoethanol
l-alpha-Hydroxy-beta-methylamino-3-hydroxy-L-ethylbenzene
l-m-Hydroxy-alpha-((methylamino)methyl)benzyl alcohol
Lopac0_000920
Lopac-P-6126
L-Phenylephedrine
L-Phenylephrine
LS-43027
Mesaton
Mesatone
Mesatonum
Metaoxedrin
Metaoxedrine
Metaoxedrinum
|
Metasympatol
Metasynephrine
Metsatonum
Mezaton
Minims phenylephrine
Minims Phenylephrine
m-Methylaminoethanolphenol
M-Methylaminoethanolphenol
MolPort-001-792-191
m-Oxedrine
M-Oxedrine
m-Sympathol
M-Sympathol
m-Sympatol
M-Sympatol
m-Synephrine
M-Synephrine
Mydfrin
NCGC00015825-01
NCGC00015825-02
NCGC00024257-03
NCGC00024257-05
NCGC00024257-06
neo Synephrine
Neofrin
Neophryn
neo-Synephrine
Neosynephrine
Neo-Synephrine
neo-Synephrine nasal drops
Neo-Synephrine Nasal Drops
neo-Synephrine nasal jelly
Neo-Synephrine Nasal Jelly
neo-Synephrine nasal spray
Neo-Synephrine Nasal Spray
neo-Synephrine pediatric nasal drops
NINDS_000597
Nostril
Nostril spray pump
Nostril Spray Pump
Nostril spray pump mild
Nostril Spray Pump Mild
Ocugestrin
Ocu-phrin sterile eye drops
Ocu-Phrin Sterile Eye Drops
Ocu-phrin sterile ophthalmic solution
P0395
PDSP1_001108
PDSP2_001092
Phenoptic
phenylephrine
Phenylephrine
Phenylephrine (INN)
Phenylephrine [INN:BAN]
Phenylephrine hydrochloride
Phenylephrine Minims
Phenylephrine Minims (TN)
Phenylephrine tannate
Phenylephrinum
Phenylephrinum [INN-Latin]
Prefrin
Prefrin liquifilm
Prefrin Liquifilm
Pyracort D
R(-)-Mezaton
R(-)-Phenylephrine
Relief eye drops for red eyes
Relief Eye Drops for Red Eyes
Rhinall
SPBio_001280
Spectrum_001101
Spectrum2_001280
Spectrum3_000770
Spectrum4_000967
Spectrum5_001411
Spersaphrine
Tannate, phenylephrine
Tannins, compds. with (R)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol
UNII-1WS297W6MV
Vicks sinex
Vicks Sinex
Visadron
|
|
27 |
|
Oxymetazoline |
Approved, Investigational |
|
|
1491-59-4 |
4636 |
Synonyms:
1491-59-4
2-(4-tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
2-(4-tert-Butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-6-tert-butyl-phenol
3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
3-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
6-t-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-Butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol
AC1L1IM1
AC-6370
Afrin Cherry 12 Hour Nasal Spray
Afrin Extra Moisturizing 12 Hour Nasal Spray
Afrin Original 12 Hour Nasal Spray
Afrin Original 12 Hour Nose Drops
Afrin Original 12 Hour Pump Mist
Afrin Sinus 12 Hour Nasal Spray
Biomol-NT_000161
BPBio1_000295
BPBio1_000419
BRD-K16195444-001-01-7
BRN 0886303
BSPBio_000267
BSPBio_002145
C07363
CAS-151615
CHEBI:142520
CHEMBL762
CID4636
D010109
D08322
DB00935
DivK1c_000567
Dristan Long Lasting Mentholated Nasal Spray
Dristan Long Lasting Nasal Mist
Drixoral Nasal Solution
Duramist Plus Up To 12 Hour Nasal Decongestant Spray
EINECS 216-079-1
FT-0082560
Genasal Nasal Spray Up to 12 Hour Relief
H 990
Hazol
HMS2089G03
HSDB 3143
Hydrochloride, oxymetazoline
IDI1_000567
Iliadin
KBio1_000567
KBio2_001531
KBio2_004099
KBio2_006667
KBio3_001645
KBioGR_000908
KBioSS_001531
L000459
Lopac0_000903
|
Lopac-O-2378
LS-104146
MolPort-002-538-313
Nafrine
Nasal Relief 12 Hour Nasal Spray
Navasin
Navisin
NCGC00015766-01
NCGC00015766-02
NCGC00015766-03
NCGC00015766-10
NCGC00022345-02
NCGC00022345-04
NCGC00022345-05
NCGC00022345-06
nchembio705-11
Neo-Synephrine 12 Hour Spray
Nezeril
NINDS_000567
Nostrilla 12 Hour Nasal Decongestant
Operil (TN)
Oximetazolina
Oximetazolina [INN-Spanish]
Oximetazolinum
Oxylazine
oxymeta zoline
Oxymetazolina
oxymetazoline
Oxymetazoline
Oxymétazoline
Oxymetazoline (INN)
Oxymetazoline [INN:BAN]
Oxymetazoline hydrochloride
oxymetazoline hydrochloride crystalline
Oxymetazoline hydrochloride crystalline
Oxymetazolinum
Oxymetazolinum [INN-Latin]
Oxymethazoline
Oxymetozoline
Phenol, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl- (9CI)
Phenol, 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl- (7CI,8CI)
Prestwick0_000224
Prestwick1_000224
Prestwick2_000224
Prestwick3_000224
Rhinofrenol
Rhinolitan
Sinerol
SPBio_001095
SPBio_002188
Spectrum_001051
Spectrum2_000998
Spectrum3_000533
Spectrum4_000464
Spectrum5_001114
Tocris-1142
UNII-8VLN5B44ZY
Vicks Sinex 12 Hour Nasal Spray
Vicks Sinex 12 Hour Ultra Fine Mist for Sinus Relief
Visine L.R
Visine L.R.
|
|
28 |
|
Metformin |
Approved |
|
|
657-24-9 |
14219 4091 |
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
cMAP_000016
D04966
DB00331
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
DMGG
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
Haurymelin
HMS2089D19
HSCI1_000295
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
|
KBioSS_002312
LA-6023
LS-43899
Melbin
metformin
Metformin
Metformin (USAN/INN)
Metformin [USAN:INN:BAN]
Metformin HCL
metformin hydrochloride
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
Sandoz Metformin
Siofor
SPBio_001928
STK011633
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
|
|
29 |
|
Pamidronate |
Approved |
|
|
40391-99-9 |
4674 |
Synonyms:
(3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid
(3-AMINO-1-HYDROXY-1-PHOSPHONO-PROPYL)PHOSPHONIC ACID
(3-amino-1-hydroxypropane-1,1-diyl)bis(phosphonic acid)
(3-amino-1-hydroxypropylidene)-1,1-biphosphonate
(3-amino-1-Hydroxypropylidene)-1,1-biphosphonate
(3-amino-1-hydroxypropylidene)-1,1-bisphosphonate
(3-amino-1-Hydroxypropylidene)-1,1-bisphosphonate
(3-Amino-1-hydroxypropylidene)bisphosphonic acid
(3-Amino-1-hydroxypropylidene)diphosphonic acid
1-hydroxy-3-aminopropane-1,1-diphosphonic acid
1-Hydroxy-3-aminopropane-1,1-diphosphonic acid
3-Amino-1-hydroxypropylidene-1,1-diphosphonate
40391-99-9
57248-88-1
57248-88-1 (di-hydrochloride salt)
AC1L1IP4
Acide pamidronique
Acide pamidronique [INN-French]
Acido pamidronico
Acido pamidronico [INN-Spanish]
Acidum pamidronicum
Acidum pamidronicum [INN-Latin]
AHPrBP
AKOS003599275
Amidronate
amino-1-hydroxypropane-1,1-diphosphonate
amino-1-Hydroxypropane-1,1-diphosphonate
aminohydroxypropylidene diphosphonate
Aminohydroxypropylidene diphosphonate
Aminomux
aminopropanehydroxydiphosphonate
Aminopropanehydroxydiphosphonate
APD
Aredia
BIDD:GT0538
Bisphosphonate 6
|
C019248
C07395
C3H11NO7P2
CHEMBL834
ChemDiv1_025240
CID4674
D07281
DB00282
EINECS 254-905-2
HMS2090C13
HMS658L06
HSCI1_000312
I14-2407
LS-174826
MolPort-002-131-054
NCGC00159433-02
NCGC00159433-03
Novartis brand of pamidronate disodium salt
Novartis brand OF pamidronate disodium salt
pamidronate
Pamidronate
pamidronate calcium
Pamidronate calcium
Pamidronate disodium
Pamidronate Disodium
PAMIDRONATE DISODIUM
pamidronate monosodium
Pamidronate monosodium
Pamidronic acid
PAMIDRONIC ACID
Pamidronic acid (INN)
Pamidronic acid [INN:BAN]
Ribodroat
Ribodroat (TN)
STOCK1N-12562
UNII-OYY3447OMC
|
|
30 |
|
Caffeine |
Approved |
|
|
58-08-2 |
2519 |
Synonyms:
07E4FB58-FD79-4175-8E3D-05BF96954522
1,3,7-trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-trimethylpurine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-trimethylxanthine
1,3,7-Trimethylxanthine
1-3-7-TRIMETHYLXANTHINE
137X
1gfz
1l5q
1l7x
1-methyltheobromine
1-Methyltheobromine
1-Methyl-theobromine
27602_FLUKA
2a3b
3,7-dihydro-1,3,7-Trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-dihydro-1,3,7-trimethyl-1H-purine
3,7-dihydro-1,3,7-Trimethyl-1H-purine-2,6-dione
5-26-13-00558 (Beilstein)
58-08-2
71701-02-5
75035_FLUKA
7-Methyl theophylline
7-methyltheophylline
7-Methyltheophylline
95789-13-2
A.S.A. and Codeine Compound
AC-12774
AC1L1DV2
AC1Q3Z23
ACon1_000085
AI3-20154
AKOS000121334
Alert-pep
Alert-Pep
Anacin Maximum Strength
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anhydrous caffeine (TN)
Anoquan
Berlin-chemie brand OF caffeine
Berlin-Chemie Brand of Caffeine
BIDD:ER0554
BIDD:GT0632
BIDD:PXR0172
BIM-0050216.0001
Bio-0579
Bio1_000473
Bio1_000962
Bio1_001451
bmse000206
BRD-K02404261-001-02-7
BRD-K02404261-001-03-5
Bristol-myers squibb brand OF caffeine
Bristol-Myers Squibb Brand of Caffeine
BRN 0017705
BSPBio_001921
C 0750
C07481
C0750_SIAL
C1778_SIAL
C2042
C6035_FLUKA
C6035_SIGMA
C7731_SIAL
C8960_SIAL
Cafamil
Cafcit
Cafecon
Cafeina
Cafeína
cafeine
Cafeine
Caféine
Cafergot
Caffedrine
Caffedrine Caplets
Caffein
Caffeina
Caffeina [Italian]
caffeine
Caffeine (natural)
Caffeine (USP)
Caffeine [BAN:JAN]
Caffeine Pure
Caffeine solution
Caffeine, anhydrous
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, synthetic
Caffeine, Synthetic
Caffeinum
caffenium
Caffine
Cafipel
CCRIS 1314
CFF
CHEBI:27732
CHEMBL113
CID2519
Coffein
Coffein [German]
Coffeine
Coffeinum
Coffeinum N
Coffeinum purrum
Coffeinum Purrum
component of Cafergot
Compound 65
CU-01000012617-3
D002110
D00528
Darvon Compound
Darvon Compound-65
Dasin
DB00201
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
DHC Plus
DHCplus
Diurex
DivK1c_000730
Durvitan
EINECS 200-362-1
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
EU-0100228
FEMA No. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline brand OF caffeine
GlaxoSmithKline Brand of Caffeine
Guaranine
HMS1920I09
HMS2091O11
HMS502E12
HSDB 36
Hycomine
|
Hycomine Compound
I14-4386
IDI1_000730
Invagesic
Invagesic Forte
KBio1_000730
KBio2_001781
KBio2_004349
KBio2_006917
KBio3_001141
KBioGR_002325
KBioSS_001781
Keep Alert
Kofein
Kofein [Czech]
Koffein
Koffein [German]
L000155
Lanorinal
Lopac0_000228
Lopac-C-0750
LS-237
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
MEGxp0_001350
Merck dura brand OF caffeine
Merck dura Brand of Caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Midol Maximum Strength
Migergot
Miudol
MLS001055341
MLS001056714
MLS001066409
MolMap_000054
MolPort-000-730-850
Monohydrate caffeine
Monomethyl derivative of Theophylline
Monomethyl Derivative of Theophylline
Natural Caffeinum
NCGC00015208-01
NCGC00015208-02
NCGC00015208-04
NCGC00015208-14
NCGC00090699-01
NCGC00090699-02
NCGC00090699-03
NCGC00090699-04
NCGC00090699-05
NCGC00090699-06
NCGC00090699-07
NCGC00090699-08
NCGC00090699-09
NCGC00168808-01
NCGC00168808-02
nchembio.243-comp7
nchembio.63-comp5
nchembio774-comp2
NCI-C02733
NCIOpen2_008255
NINDS_000730
Nix Nap
no Doz
No Doz
Nodaca
No-Doz
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
NSC 5036
NSC5036
Organex
Orphengesic
Orphengesic Forte
P-A-C Analgesic Tablets
Passauer brand OF caffeine
Passauer Brand of Caffeine
PDSP1_001016
PDSP1_001235
PDSP2_001000
PDSP2_001219
Pep-Back
Percoffedrinol N
Percutafeine
Percutaféine
Phensal
Pierre fabre brand OF caffeine
Pierre Fabre Brand of Caffeine
Probes1_000150
Probes2_000128
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick Pep
Quick-pep
Quick-Pep
Refresh'n
Republic drug brand OF caffeine
Republic Drug Brand of Caffeine
SDCCGMLS-0064595.P001
SDCCGMLS-0064595.P002
Seid brand OF caffeine
Seid Brand of Caffeine
SK 65 Compound
SK-65 Compound
SMR000326667
SPBio_001222
Spectrum_001301
SPECTRUM1500155
Spectrum2_001261
Spectrum3_000321
Spectrum4_001782
Spectrum5_000423
Stim
STK177283
Synalgos-Dc
teina
Teina
Teína
Thein
Theine
Theobromine Me
Theobromine ME
Theophylline Me
Theophylline ME
Theophylline, 7-methyl
Thompson brand 1 OF caffeine
Thompson Brand 1 of Caffeine
Thompson brand 2 OF caffeine
Thompson Brand 2 of Caffeine
Tirend
TNP00310
Triad
Tri-Aqua
Ultra Pep-Back
UNII-3G6A5W338E
Vivarin
W222402_ALDRICH
Wake-Up
Wigraine
WLN: T56 BN DN FNVNVJ B1 F1 H1
Xanthine, 1,3,7-trimethyl
ZINC00001084
|
|
31 |
|
mometasone furoate |
Approved, Investigational, Vet_approved |
|
|
83919-23-7 |
|
Synonyms:
|
Mometasone furoate anhydrous
|
|
32 |
|
tannic acid |
Approved |
|
|
1401-55-4 |
|
Synonyms:
ácido tánico
Gallotannic acid
|
|
|
33 |
|
Benzocaine |
Approved, Investigational |
|
|
94-09-7, 1994-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-aminobenzoic acid ethyl ester
4-amino-benzoic acid ethyl ester
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
Acetate, benzocaine
Acetate, Benzocaine
AE-562/40377256
Aethoform
Aethylium paraminobenzoicum
AI3-02081
AKOS000119763
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
AR-1H9065
Baby anbesol
Baby Anbesol
BB_SC-0019
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
benzocaine
Benzocaine
Benzocaine (USP/INN)
Benzocaine [INN:BAN]
Benzocaine acetate
Benzocaine Acetate
Benzocaine formate
Benzocaine Formate
Benzocaine hydrobromide
Benzocaine Hydrobromide
Benzocaine hydrochloride
Benzocaine Hydrochloride
Benzocaine methanesulfonate
Benzocaine Methanesulfonate
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
C07527
CAS-94-09-7
Caswell No. 430A
CHEBI:116735
CHEMBL278172
Chloraseptic
CID2337
D001566
D00552
DB01086
Dermoplast
Diet ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
|
Ethyl aminobenzoic acid
Ethyl PABA
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl P-aminobenzoate
Ethyl P-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl P-aminophenylcarboxylate
Ethyl P-aminophenylcarboxylic acid
ethylaminobenzoate-4
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny P-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
ETHYL-P-AMINOBENZOATE
Formate, benzocaine
Formate, Benzocaine
h-4-abz-oet
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, benzocaine
Hydrobromide, Benzocaine
Hydrochloride, benzocaine
Hydrochloride, Benzocaine
I05-0204
Identhesin
IDI1_000932
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
Methanesulfonate, benzocaine
Methanesulfonate, Benzocaine
MLS001331704
MLS002153970
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
nchembio.182-comp4
NINDS_000932
Norcain
Norcaine
Norcainum
NSC 122792
NSC 41531
NSC41531
NSC4688
Oprea1_750694
Oprea1_827402
Orabase-b
Ora-jel
Orthesin
Otocain
Outgro
p-(Ethoxycarbonyl)aniline
P-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
P-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
Parathesin
Parathesin (TN)
Parathesine
p-Carbethoxyaniline
P-Carbethoxyaniline
p-Ethoxycarboxylic aniline
P-Ethoxycarboxylic aniline
Prestwick_991
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Slim mint gum
SMR000059025
Solarcaine
Solu H
SPBio_000134
SPBio_002844
Spectrum_000074
SPECTRUM1500139
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
STK043620
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
|
|
34 |
|
Vasoconstrictor Agents |
|
|
|
|
|
35 |
|
Insulin, Globin Zinc |
|
|
|
|
|
36 |
|
Hypoglycemic Agents |
|
|
|
|
|
37 |
|
insulin |
|
|
|
|
|
38 |
|
Anti-Infective Agents, Local |
|
|
|
|
|
39 |
|
Pharmaceutical Solutions |
|
|
|
|
|
40 |
|
Calamus |
|
|
|
|
|
41 |
|
Cola |
|
|
|
|
|
42 |
|
Anesthetics |
|
|
|
|
|
43 |
|
Anesthetics, General |
|
|
|
|
|
Interventional clinical trials:
(show top 50)
(show all 90)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Multi-Center, Randomized, Double-Blind Active-Controlled, Parallel Group Study to Investigate Plasma Folate, Red Blood Cell Folate and Homocysteine Levels During a 24 Week Oral Administration of an OC Containing Folate Compared to OC Alone |
Completed |
NCT00468481 |
Phase 3 |
Drospirenone/Ethinylestradiol/Methyltetrahydrofolate;Drospirenone/Ethinylestradiol (Yaz) |
2 |
A Randomized, Double-Blind, Two-Part, Parallel-Group, Comparative Study to Evaluate Blood Folate Levels in Women Taking an Oral Contraceptive With and Without Folic Acid |
Withdrawn |
NCT00301587 |
Phase 3 |
Norgestimate-ethinyl estradiol, with or without folic acid |
3 |
Post Transplant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidative Therapy After Non-Myeloablative Allogeneic Transplantation in Patients With Myelodysplasia or Myeloproliferative Disorders |
Completed |
NCT01392989 |
Phase 2 |
CIK cells;Cyclosporine;Mycophenolate Mofetil;Thymoglobulin |
4 |
Lumbar to Sacral Ventral Nerve Re-Routing |
Completed |
NCT00378664 |
Phase 2 |
|
5 |
Coping Skills Training (CST) for Children With Chronic Health Conditions: An Extension From Children With Diabetes to Children With Rheumatologic Conditions, Epilepsy, Spina Bifida, and Asthma |
Completed |
NCT00359775 |
Phase 2 |
|
6 |
Probiotics Improvement of Gastrointestinal and Genitourinary Health in Girls With Spina Bifida (H-23245) |
Withdrawn |
NCT00767988 |
Phase 2 |
|
7 |
Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study) |
Completed |
NCT00452829 |
Phase 1 |
Folic Acid and inositol;Folic acid and placebo |
8 |
Study to Compare 2 Minimally Invasive Fetal Neural Tube Defect Repair Techniques: Repair Using Durepair Patch vs. Repair Without Durepair Patch |
Recruiting |
NCT03794011 |
Phase 1 |
|
9 |
Minimally Invasive Fetal Neural Tube Defect Repair Study |
Active, not recruiting |
NCT02230072 |
Phase 1 |
|
10 |
Genetics of Neural Tubes Defects |
Unknown status |
NCT01253746 |
|
|
11 |
Assessment of Functional Independence and Quality of Life in Italian Population of Adolescents With Spina Bifid |
Unknown status |
NCT00966927 |
|
|
12 |
Interrater and Intrarater Reliability of Infant Motor Profile: Assessing Motor Profiles of Risky Infants |
Unknown status |
NCT03188107 |
|
|
13 |
The Spina Bifida Research Resource |
Unknown status |
NCT00031122 |
|
|
14 |
Powder Topical Rifampicin on Reducing Infections After Neural Tube Defect Surgery in Infants |
Unknown status |
NCT03198819 |
|
Local Rifampisin and İnrtravenous cefotaxime |
15 |
The LETS Study: A Longitudinal Evaluation of Transition Services |
Unknown status |
NCT00975338 |
|
|
16 |
Open Spina Bifida Fetoscopic Repair Project |
Unknown status |
NCT03562286 |
|
|
17 |
Incidence of Pregnancies and Births With Spina Bifida in Denmark in 2008-2014 |
Unknown status |
NCT02685813 |
|
|
18 |
Echocardiography Based Algorithm for Prevention and Treatment of Spinal Hypotension- A Prospective Randomised Controlled Study |
Unknown status |
NCT03106649 |
|
|
19 |
Hemangioma Associated With High Rates of Morbidity:A Prospective Study |
Completed |
NCT00394888 |
|
|
20 |
Treatment of Persistent Urinary Incontinence in Children |
Completed |
NCT00124046 |
|
|
21 |
Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects? |
Completed |
NCT04135274 |
|
|
22 |
Improving Genetic Counseling for Patients With Spina Bifida Using Next Generation Sequencing |
Completed |
NCT02854150 |
|
|
23 |
Urinary Markers of Detrusor Overactivity in Spina Bifida Patients |
Completed |
NCT02852317 |
|
|
24 |
Fetal Spina Bifida -Prenatal Course and Outcome in 103 Cases A Single Center Experience. |
Completed |
NCT01100697 |
|
|
25 |
Can Dynamic Ultrasonography Replace Urodynamics in the Follow-up of Patients With Myelomeningocele: A Prospective Concurrent Study |
Completed |
NCT03550898 |
|
|
26 |
Blood Folate and Homocysteine Levels Following Administration of Folic Acid According to Different Daily Dosing Schedules:a Simulation of Food Fortification |
Completed |
NCT00207558 |
|
folic acid |
27 |
Dosage Effects of Folic Acid on Blood Folates of Honduran Women |
Completed |
NCT00207532 |
|
folic acid |
28 |
Metformin in Children With Motor Deficit |
Completed |
NCT00720161 |
|
Metformin;placebo |
29 |
Impact of Prenatal Correction of Spina Bifida Using Fetoscopy and the SAFER Technique on Long-term Neurodevelopment. |
Completed |
NCT04356703 |
|
|
30 |
A Randomized Exercise Trial for Wheelchair Users |
Completed |
NCT00866112 |
|
|
31 |
Efficacy of Weekly Versus Daily Folic Acid Supplementation |
Completed |
NCT00394862 |
|
multivitamin |
32 |
The Relationship Between Nocturnal Enuresis And Spina Bifida Occulta: A Prospective Controlled Trial |
Completed |
NCT03543995 |
|
|
33 |
Prevention of Post Operative Bone Loss in Children |
Completed |
NCT00655681 |
|
pamidronate |
34 |
Retrograde Colonic Irrigation to Manage Spina Bifida Functional Digestive Sequelae: a Multicenter, Prospective, Randomized Controlled Trial |
Completed |
NCT02361450 |
|
|
35 |
Pilot Study of Folate Pharmacokinetics in Normal Weight and Obese Women of Child-bearing Age |
Completed |
NCT01743196 |
|
|
36 |
Characterization of At-risk Population and Prognosis Factors for SACRO-coccygeal Teratoma in CURRARINO Syndrome. A Clinical, Molecular and Pathological Study. |
Completed |
NCT00780117 |
|
|
37 |
Use of a Diurnal Indwelling Urethral Catheter to Improve Quality of Life for Patients With Spina Bifida and Spinal Cord Injury |
Completed |
NCT03573726 |
|
|
38 |
Influence of "Espresso" on Adsorption of Orally Administrated Myo-inositol in Humans |
Completed |
NCT01244399 |
|
|
39 |
Investigation of Parents' Anxiety Level and Health Related Quality of Life in Different Types of Physical Disabilities |
Completed |
NCT04035967 |
|
|
40 |
Medication Management Among Individuals With Neurodevelopmental Disabilities |
Completed |
NCT03121651 |
|
|
41 |
Myelomeningocele Repair Randomized Trial |
Completed |
NCT00060606 |
|
|
42 |
Efficacy of a Wheelchair Propulsion Training Program for Manual Wheelchair Users: a Pilot Study |
Completed |
NCT04009187 |
|
|
43 |
Parental Perspectives of Using Modified Toy Cars on the Social Interactions of Preschool Children With Mobility Impairments. |
Completed |
NCT02682043 |
|
|
44 |
An Audit of the Posterior Fossa Characterization in Open Spina Bifida Based on Tertiary Center Experience |
Completed |
NCT03544970 |
|
|
45 |
3D-printed Module-assisted Minimally Invasive Lumbar Pedicle Screw Placement: a Retrospective, Self-controlled, Open-label Clinical Trial |
Completed |
NCT02970578 |
|
|
46 |
Randomized Clinical Trial Using Sterile Single-use and Reused Polyvinylchloride Catheter For Intermittent Catheterization With Clean Technique In Neurogenic Bladder Due to Spina Bifida |
Completed |
NCT03424499 |
|
|
47 |
Computer-based and Virtual Assessment of Power Wheelchair Mobility |
Completed |
NCT00951509 |
|
|
48 |
The Effectiveness of Participation-focused Interventions on Body Functions of Youth With Physical Disabilities: An Interrupted Time Series Design |
Completed |
NCT03851107 |
|
|
49 |
A Comparison of the Incidence of Symptomatic Urinary Tract Infections in Children With Spina Bifida Using Hydrophilic or Non-hydrophilic Polyvinyl Chloride Catheters for Clean Intermittent Catheterization: a Randomized Cross Over Trial |
Completed |
NCT01263392 |
|
|
50 |
Cognitive Rehabilitation in Patients With Spina Bifida: Effects on Executive Functions, Psychological and Health Related Factors |
Completed |
NCT01302314 |
|
|
|